Targeted Combination Therapy Read more about Targeted Combination Therapy Canada3059882Filed on 2018-04-11
Targeted Combination Therapy Read more about Targeted Combination Therapy BrazilBR112019021476-3Filed on 2018-04-11
Targeted Combination Therapy Read more about Targeted Combination Therapy Australia2018251788Filed on 2018-04-11
Antisense Oligos That Block Cancer Cell Migration And Invasion Read more about Antisense Oligos That Block Cancer Cell Migration And Invasion US Application 17/792,507Filed on 2022-07-13
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION US Application 17/802,464Filed on 2022-08-25
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION United Kingdom2212195.8Filed on 2022-08-22
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION Singapore11202252357KFiled on 2022-08-19
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION South Korea2022-7033222Filed on 2022-09-23
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION Japan2022-551537Filed on 2022-08-25
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION India202247052620Filed on 2022-09-14